EMEA-000876-PIP02-11-M01

  • Email
  • Help

Overview

Product details for Soliris
Invented nameSoliris
Active substance

Eculizumab

Decision numberP/0306/2012
PIP numberEMEA-000876-PIP02-11-M01
Pharmaceutical form(s)Concentrate for solution for infusion
Condition(s)/indication(s)

Treatment of Shiga-toxin-producing Escherichia coli haemolytic uraemic syndrome

Route(s) of administrationIntravenous use
PIP applicant

Alexion Europe SAS
France
E-mail: pip.enquiries.eu@alxn.com 
Tel. +33 1 47 10 06 06
Fax +33 1 47 10 06 11

Decision typePM: decision on the application for modification of an agreed PIP

Decision

Related information